By Professor Anne Margaret Keogh

Journal articles

Menache A; Keogh A, 2013, 'Regarding "A process-based review of mouse models of pulmonary hypertension"', Pulmonary Circulation, 3, pp. 447 - 447, http://dx.doi.org/10.4103/2045-8932.114782

Rubin L; Galiè N; Grimminger F; Grünig E; Humbert M; Jing Z-C; Keogh A; Langleben D; Fritsch A; Menezes F; Neuser D; Ghofrani H, 2013, 'Riociguat for the Treatment of Pulmonary Arterial Hypertension (PAH): 1-Year Results from the PATENT-2 Long-term Extension Study', Chest, 144, pp. 1024A - 1024A, http://dx.doi.org/10.1378/chest.1783307

Grover R; Sevastos J; Hayward C; Jabbour A; Keogh A; Kotlyar E; Macdonald P, 2013, 'Tenckhoff Catheter Implantation and Modified Peritoneal Dialysis As a Novel Therapeutic Approach in Diuretic Resistant Congestive Heart Failure: A Single-centre Case-series', Heart, Lung and Circulation, 22, pp. S89, http://dx.doi.org/10.1016/j.hlc.2013.05.211

Strange G; Gabbay E; Kermeen F; Williams T; Carrington M; Stewart S; Keogh A, 2013, 'Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: The delay study', Pulmonary Circulation, 3, pp. 89 - 94, http://dx.doi.org/10.4103/2045-8932.109919

Galiè N; Corris PA; Frost A; Girgis RE; Granton J; Jing ZC; Klepetko W; McGoon MD; McLaughlin VV; Preston IR; Rubin LJ; Sandoval J; Seeger W; Keogh A, 2013, 'Updated Treatment Algorithm of Pulmonary Arterial Hypertension', Journal of the American College of Cardiology, 62, pp. D60 - D72, http://dx.doi.org/10.1016/j.jacc.2013.10.031

Rubin LJ; Simonneau G; Badesch D; Galiè N; Humbert M; Keogh A; Massaro J; Cerinic MM; Sitbon O; Kymes S, 2012, 'The study of risk in pulmonary arterial hypertension', European Respiratory Review, 21, pp. 234 - 238, http://dx.doi.org/10.1183/09059180.00003712

Badesch D; Feldman J; Keogh AM; Mathier M; Oudiz R; Shapiro S; Farber H; McGoon M; Frost A; Allard M; Despain D; Dufton C, 2012, 'ARIES-3: Ambrisentan therapy is a diverse population of patients with pulmonary hypertension', Journal Cardiovascular Pharmacology and Therapentics, 30, pp. 93 - 99, http://dx.doi.org/10.1111/j.1755-5922.2011.00279.x

Gomberg-Maitland M; Oudiz R; Shapiro S; Keogh A; Badesch D; Frantz R; Gregory Elliott C; Gillies H; Walker G; Waxman A, 2012, 'Cicletanine as Add-on Therapy for Pulmonary Arterial Hypertension', Chest, 142, pp. 806A - 806A, http://dx.doi.org/10.1378/chest.1386552

Dalton BA; McNeil K; Keogh AM; Williams T; Proudman S; Gabbay E; Kotlyar E; Weintraub R, 2012, 'Design and delivery of an e-learning curriculum for physicians involved with the management of pulmonary hypertension', International Journal of Clinical Practice, 66, pp. 1117 - 1124, http://dx.doi.org/10.1111/j.1742-1241.2012.02997.x

Muthiah K; Robson D; Pritchard R; Walker R; Macdonald P; Keogh A; Kotlyar E; Spratt P; Dhital K; Granger E; Jansz P; Hayward C, 2012, 'Effect of Concomitant Speed Increase with Exercise on Invasively Measured Haemodynamics in Patients with Continuous Flow Left Ventricular Assist Devices (LVADs)', Heart, Lung and Circulation, 21, pp. S79 - S79, http://dx.doi.org/10.1016/j.hlc.2012.05.200

Muthiah K; Connor D; Ly K; Robson D; Macdonald P; Keogh A; Kotlyar E; Spratt P; Granger E; Dhital K; Jansz P; Joseph J; Hayward C, 2012, 'Longitudinal Investigation of the Effect of Centrifugal Continuous Flow Left Ventricular Assist Devices (cfLVADS) on Blood Haemostatic Parameters', Heart, Lung and Circulation, 21, pp. S85 - S85, http://dx.doi.org/10.1016/j.hlc.2012.05.216

Rinaldi M; Wang SS; Hirt S; Eisen H; Keogh A; Boffini M; Bara C; Zuckermann A; Lopez P; Cines M; Lehmkuhl H, 2012, 'mTOR-Inhibitor-Attributed Events: Review of 2-Year Safety Data in Heart Transplant Recipients Receiving Everolimus Vs MMF in the Randomised Multi-Centre 2310 Study', Transplantation Journal, 94, pp. 129 - 129, http://dx.doi.org/10.1097/00007890-201211271-00239

Tapson V; Torres EM; Kermeen F; Keogh AM; Allen R; Frantz R; Frost A; Shapiro S; Laliberte A; Sigman J; Arneson C; Galie N, 2012, 'Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background Endothelin receptor antagonist and or phosphodiesterase type 5 inhibitor (the FREEDOM-C study).', Chest, 142, pp. 1383 - 1390, http://www.mdconsult.com.wwwproxy0.library.unsw.edu.au/das/article/body/405121838-2/jorg=journal&source=&sp=25983121&sid=0/N/1119533/1.html?issn=0012-3692

Lithander FE; Keogh AM; Killeen L, 2012, 'Overweight and obesity among older adults on admission to hospital', Irish Medical Journal, 104, pp. 87 - 88, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21667614

Zuckermann A; Keogh AM; Crespo-leiro M; Mancini D; Gonzalez-Vilchez ; Almenar L; Brozena S; Eisen H; Tai S; Kushwaha S, 2012, 'Randomized controlled trail of sirolimus conversion in cardiac transplant recipients with renal insufficiency', American Journal of Transplantation, 12, pp. 2487 - 2497, http://dx.doi.org/10.1111/j.1600-6143.2012.04131.x

Muthiah K; Robson D; Walker R; Otton J; Macdonald P; Keogh A; Kotlyar E; Spratt P; Dhital K; Granger E; Jansz P; Hayward C, 2012, 'Relationship Between Heart Rate and Pump Flow in Patients Implanted with Continuous Flow Left Ventricular Assist Devices (LVAD)', Heart, Lung and Circulation, 21, pp. S91 - S91, http://dx.doi.org/10.1016/j.hlc.2012.05.231

Ghofrani H; Galie N; Grimminger F; Humbert M; Keogh A; Langleben D; Ochan Kilama M; Neuser D; Rubin L, 2012, 'Riociguat for the Treatment of Pulmonary Arterial Hypertension: A Randomized, Double-Blind, Placebo-Controlled Study (PATENT-1)', Chest, 142, pp. 1027A - 1027A, http://dx.doi.org/10.1378/chest.1462799

Imran M; Keogh A; Kotylar E; Hayward C; Macdonald P; Prichard R, 2012, 'Role of Bosentan in Patients with High Transpulmonary Gradient (TPG) Secondary to Advanced Left Heart Failure (LHF) and Awaiting Left Ventricular Assist Device (LVAD) or Heart Transplant', Heart, Lung and Circulation, 21, pp. S91 - S92, http://dx.doi.org/10.1016/j.hlc.2012.05.232

Muthiah K; Chye A; Wainwright C; Macdonald P; Keogh A; Kotlyar E; McCrohon J; Hayward C, 2012, 'Validation of 3-D Echocardiography with Cardiac MRI for the Assessment of Chamber Function in Patients with Cardiomyopathy', Heart, Lung and Circulation, 21, pp. S233 - S233, http://dx.doi.org/10.1016/j.hlc.2012.05.575

Kobashigawa J; Pauly D; Ross H; Wang S; Cantin B; Burton J; Keogh A; Eisen H; Lopez P; Dong G; Jiang H; Cines M; Starling R, 2011, '52 Reduction of Cardiac Allograft Vasculopathy with Everolimus over Mycophenolate Mofetil: Intravascular Ultrasound Results of a Randomized Multicenter Trial', The Journal of Heart and Lung Transplantation, 30, pp. S24 - S25, http://dx.doi.org/10.1016/j.healun.2011.01.059

Zuckermann A; Keogh A; Crespo-Leiro MG; Mancini D; Gonzalez Vilchez F; Almenar L; Eisen H; See Tai S; Kushwaha S, 2011, '56 Safety and Efficacy of Conversion to Sirolimus vs Continued Calcineurin Inhibitor Use in Cardiac Transplant Recipients with Renal Insufficiency', The Journal of Heart and Lung Transplantation, 30, pp. S26 - S26, http://dx.doi.org/10.1016/j.healun.2011.01.063

Pauly D; Starling R; Kobashigawa J; Wang S; Cantin B; Keogh A; Lehmkuhl H; Hirt S; Lopez P; Dong G; Cines M; Jiang H; Eisen H, 2011, '57 Heart Transplant Recipients Treated with Everolimus Have Less Increase in Intimal Thickness vs MMF, Irrespective of Lipid Values', The Journal of Heart and Lung Transplantation, 30, pp. S26 - S27, http://dx.doi.org/10.1016/j.healun.2011.01.064

Muthiah K; Phan J; Robson D; Macdonald P; Keogh A; Kotlyar E; Granger E; Dhital K; Spratt P; Jansz P; Hayward C, 2011, 'Development of Aortic Regurgitation/Insufficiency Following Implantation of Continuous Flow Left Ventricular Assist Device (LVAD) and Outcomes', Heart, Lung and Circulation, 20, pp. S63 - S63, http://dx.doi.org/10.1016/j.hlc.2011.05.158

Hayward CS; Salamonsen RF; Keogh AM; Woodward JC; Ayre PJ; Prichard RS; Kotlyar E; Mcdonald PS; Jansz PC; Spratt P, 2011, 'Effect of alteration in pump speed on pump output and left ventricular filling with continuous-flow left ventricular assist device', ASAIO Journal, 57, pp. 495 - 500, http://dx.doi.org/10.1097/MAT.0b013e318233b112

Hu S; Keogh A; Macdonald P; Kotlyar E; Robson D; Harkess M; Jansz P; Spratt P; Hayward C, 2011, 'Effect of Physical Activity on Continuous-Flow Left Ventricular Assist Device Function in Outpatients', Heart, Lung and Circulation, 20, pp. 276 - 277, http://dx.doi.org/10.1016/j.hlc.2010.11.059

Buchholz S; Ali F; Kotlyar E; Hayward C; Keogh A; MacDonald P; Feneley M, 2011, 'Effectiveness of Atropine as a Chronotropic Adjunct in Cardiac Transplant Recipients Undergoing Dobutamine Stress Echocardiography', Heart, Lung and Circulation, 20, pp. S173 - S173, http://dx.doi.org/10.1016/j.hlc.2011.05.429

Zuckermann A; Wang S-S; Ross H; Frigerio M; Eisen HJ; Bara C; Hoefer D; Cotrufo M; Dong G; Junge G; Keogh AM, 2011, 'Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized Trial.', J Transplant, 2011, pp. 535983, http://dx.doi.org/10.1155/2011/535983

Muthiah K; Phan J; Robson D; Macdonald P; Keogh A; Kotlyar E; Granger E; Dhital K; Spratt P; Jansz P; Hayward C, 2011, 'Left Ventricular Assist Devices in Patients with Hypertrophic Cardiomyopathy', Heart, Lung and Circulation, 20, pp. S69 - S70, http://dx.doi.org/10.1016/j.hlc.2011.05.174

Strange G; Manterfield C; Miller T; Pidoux A; Brown K; Williams TJ; Gabbay E; Keogh AM, 2011, 'Non-parenteral therapy for pulmonary arterial hypertension: a review of efficacy, tolerability and factors related to patient adherence', Clinical Medicine Insights: Therapeutics, 3, pp. 1 - 13, http://dx.doi.org/10.4137/CMT.S2689

Strange G; Keogh AM; Gabbay E, 2011, 'Pharmacoeconomic evidence of bosentan for pulmonary arterial hypertension', Expert Review of Pharmacoeconomics and Outcomes Research, 11, pp. 253 - 263

Iyer A; Kumarasinghe G; Hicks M; Watson A; Gao L; Keogh AM; Kotlyar E; Hayward CS; Dhital K; Granger EK; Jansz PC; Mcdonald PS; Pye R; Spratt P, 2011, 'Primary graft failure after heart transplantation', Journal of Heart and Lung Transplantation, pp. 1 - 9, http://dx.doi.org/10.1155/2011/175768

Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz PC; Hayward CS, 2011, 'Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes', Journal of Heart and Lung Transplantation, 30, pp. 888 - 895, http://dx.doi.org/10.1016/j.healun.2011.03.006

Keogh AM; Strange G; Kotlyar E; Williams TJ; Kilpatrick D; Macdonald PS; Brown K; Pidoux A; Kermeen F; Steele PA; Dalton BA; Gabbay E, 2011, 'Survival after the initiation of combination therapy in patients with pulmonary arterial hypertension: an Australian collaborative report', Internal Medicine Journal, 41, pp. 235 - 244, http://dx.doi.org/10.1111/j.1445-5994.2010.02403.x

Strange G; Keogh A; Stewart S; Carrington M; Kermeen F; Williams T; Gabbay E, 2011, 'Symptoms to Definitive Diagnosis of Pulmonary Arterial Hypertension (PAH)', Heart, Lung and Circulation, 20, pp. S217 - S217, http://dx.doi.org/10.1016/j.hlc.2011.05.533

Keogh AM; Strange G; McNeil K; Williams T; Gabbay E; Proudman S; Weintraub R; Wlodarczyk J; Dalton BA, 2011, 'The bosentan patient registry: long-term survival in pulmonary arterial hypertension', Internal Medicine Journal, 41, pp. 227 - 234, http://dx.doi.org/10.1111/j.1445-5994.2009.02139.x

Phan J; Macdonald P; Keogh A; Kotlyar E; Pritchard R; Hayward C, 2011, 'Vasoreactivity Testing with Inhaled Iloprost and Nitric Oxide in Pulmonary Arterial Hypertension', Heart, Lung and Circulation, 20, pp. S78 - S78, http://dx.doi.org/10.1016/j.hlc.2011.05.194

Peacock A; Keogh A; Humbert M, 2010, 'Endpoints in pulmonary arterial hypertension: The role of clinical worsening', Current Opinion in Pulmonary Medicine, 16, http://dx.doi.org/10.1097/01.mcp.0000370205.22885.98

Costanzo MR; Dipchand A; Starling R; Anderson A; Chan M; Desai S; Fedson S; Fisher P; Gonzales-Stawinski G; Martinelli L; McGiffin D; Smith J; Taylor D; Meiser B; Webber S; Baran D; Carboni M; Dengler T; Feldman D; Frigerio M; Kfoury A; Kim D; Kobashigawa J; Shullo M; Stehlik J; Teuteberg J; Uber P; Zuckermann A; Hunt S; Burch M; Bhat G; Canter C; Chinnock R; Crespo-Leiro M; Delgado R; Dobbels F; Grady K; Kao W; Lamour J; Parry G; Patel J; Pini D; Towbin J; Wolfel G; Delgado D; Eisen H; Goldberg L; Hosenpud J; Johnson M; Keogh A; Lewis C; O'Connell J; Rogers J; Ross H; Russell S; Vanhaecke J; Rowe AW, 2010, 'The international society of heart and lung transplantation guidelines for the care of heart transplant recipients', Journal of Heart and Lung Transplantation, 29, pp. 914 - 956, http://dx.doi.org/10.1016/j.healun.2010.05.034

Zuckermann A; Keogh A; Crespo-Leiro MG; Mancini D; Gonzalez-Vilchez F; Almenar L; Brozena S; Eisen H; See Tai S; Kashwaha S, 2010, '249: A Randomized, Open-Label Study To Compare the Safety and Efficacy of Conversion From a Calcineurin Inhibitor (CNI) to Sirolimus Versus Continued Use of a CNI in Cardiac Transplant Recipients with Mild to Moderate Renal Insufficiency', The Journal of Heart and Lung Transplantation, 29, pp. S85 - S85, http://dx.doi.org/10.1016/j.healun.2009.11.260

Harkess M; Keogh A; Macdonald P; Pettersson R; Hayward C, 2010, 'Cardiac Transplant Outcome With Donor Hearts Over 50 Years of Age', Heart, Lung and Circulation, 19, pp. S66 - S66, http://dx.doi.org/10.1016/j.hlc.2010.06.822

Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman C; Elsik M; Krum H; Hayward CS, 2010, 'Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial', Journal of the American College of Cardiology, 55, pp. 1780 - 1787, http://dx.doi.org/10.1016/j.jacc.2010.01.024

Crespo-Leiro MG; Zuckermann A; Keogh A; Mancini D; González-Vilchez F; Almenar L; Brozena S; Eisen H; Tai SS; Kushwaha S, 2010, 'EFFECT OF CONVERSION FROM CALCINEURIN INHIBITORS (CNIS) TO SIROLIMUS ON RENAL FUNCTION IN CARDIAC TRANSPLANT RECIPIENTS WITH MILD TO MODERATE RENAL INSUFFICIENCY: INTERIM SAFETY AND EFFICACY RESULTS', Transplantation Journal, 90, pp. 122 - 122, http://dx.doi.org/10.1097/00007890-201007272-00236

Steele PA; Strange G; Dalton B; Stewart SP; Gabbay E; Keogh AM, 2010, 'Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?', BMC Cardiovascular Disorders, 10, pp. 1 - 7

Hayward C; Salamonsen R; Prichard R; Walker R; Keogh A; Macdonald P; Woodard J; Kotlyar E; Jansz P; Spratt P, 2010, 'Impact of Left Ventricular Assist Device Pump Speed on Exercise Capacity and Cardiopulmonary Function—A Randomised Crossover Trial', Heart, Lung and Circulation, 19, pp. S72 - S72, http://dx.doi.org/10.1016/j.hlc.2010.06.836

Hayward C; Salamonsen R; Keogh A; Macdonald P; Kotlyar E; Prichard R; Walker R; Woodard J; Jansz P; Spratt P, 2010, 'Invasive Assessment of Changes in Continuous Flow Left Ventricular Assist Device Function Due to Exercise and Increased Pump Speed', Heart, Lung and Circulation, 19, pp. S74 - S74, http://dx.doi.org/10.1016/j.hlc.2010.06.841

Jabbour A; Hayward CS; Keogh AM; Kotlyar E; Mccrohon JA; England JF; Amor R; Liu X; Zhou MD; Graham RM; Macdonald PS, 2010, 'Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses', European Journal of Heart Failure, 13, pp. 83 - 92, http://dx.doi.org/10.1093/eurjhf/hfq152

Harris J; Keogh A; Hayward C; Prichard R; Phan J, 2010, 'Safety of Right Heart Catheterisation in a Non-fasting, Anticoagulated Population', Heart, Lung and Circulation, 19, pp. S226 - S226, http://dx.doi.org/10.1016/j.hlc.2010.06.549

Hu S; Keogh A; Macdonald P; Kotlyar E; Robson D; Harkess M; Jansz P; Spratt P; Hayward C, 2010, 'The Interaction Between Physical Activity and Centrifugal Continuous Flow Left Ventricular Assist Device Function', Heart, Lung and Circulation, 19, pp. S82 - S82, http://dx.doi.org/10.1016/j.hlc.2010.06.859

Keogh AM, 2009, 'An incomplete 25 year history of heart transplantation at st. vincent's hospital sydney', Transplant Nurses Journal, 18, pp. 7 - 8

Ross H; Lehmkuhl H; Wang S-S; Vigano M; Zuckermann A; Varnous S; Frigerio M; Laufer G; Potena L; Keogh A; Livi U, 2009, 'Dynamics of Pleural Effusions in the Presence of Everolimus-Based Immunosuppression in De Novo Cardiac Transplant Recipients', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 28, pp. S202 - S202, http://dx.doi.org/10.1016/j.healun.2008.11.401

Back to profile page